Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Caplin Point Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 310.30 0.10  | 0.03% -22.04% 11.48 2,332.07
NSE Price: Dec 09, 12:34 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Dec 09, 12:34 310.30 0.10 0.03% 313.90 310.20 43,714 308.55 - 317.55
BSE Dec 09, 12:38 309.80 -0.30 -0.10% 372.00 310.10 1,373 308.25 - 372.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 51,533 P/B: 3.00 NSE Code: CAPLIPOINT
52-Week Range: R 295.00 - 466.90 Dividend Yield: 0.71% BSE Code: 524742
TTM EPS: R 26.86 Book Value: R 102.64 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Caplin Point Laboratories -18.79 -20.85 -27.16 -21.85 -4.46 29.11 68.43
S&P BSE Small Cap -9.30 -0.99 5.91 -5.68 3.12 3.05 5.44
S&P BSE Healthcare -4.13 0.89 3.06 -2.40 -5.21 -2.21 10.22
Company's return has been calculated on basis of BSE's price.
As on Dec 06, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 20.16 39.55 -
Net Profit 22.07 56.83 -
EPS 21.90 56.78 -
Book Value 73.58 72.06 -
Average
Operating Margin 38.68 36.92 31.19
Net Margin 26.44 25.27 20.92
Return on Networth 35.79 46.73 48.72
Return on Investment 45.59 59.57 62.37
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 18.00 45.77 21.28
Operating Profit 8.57 24.22 15.70
Net Profit 14.38 31.67 14.87
EPS 14.10 31.68 15.06
TTM
Revenue 10.27 30.44 18.10
Operating Profit 5.69 27.28 12.95
Net Profit 7.28 32.11 14.98
EPS 7.28 32.03 15.05
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Caplin Point Laboratories 2,332.07 766.12 203.01 25.77 35.79 3.00 11.48
Astrazeneca Pharma India 6,874.75 818.54 74.85 8.97 20.03 20.86 91.85
Procter & Gamble Health 7,087.94 894.23 835.89 14.21 73.79 9.09 52.88
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Feb 11, 2019 Sridhar Ganesan  Buy ESOP 26,750 350.70 93.81
Aug 10, 2018 Matthews India Fund  Buy Market 92,607 398.65 369.18
Jun 06, 2018 C C Paarthipan  Buy Market 10,427 396.75 41.37
Jun 06, 2018 C C Paarthipan  Buy Open Market 10,427 396.75 41.37
Jun 06, 2018 Dr Sridhar Ganesan  Buy Market 8,000 396.75 31.74
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Motilal Oswal Mutual Fund 0.001 - - - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Caplin Point Laboratories Ltd.

Address: Narbavi, No . 3, Lakshmanan Street, T Nagar, Chennai, Tamil Nadu - 600017 | Phone: 91-044-28156653 / 28156905 | Fax: 91-044-28154952

Email: [email protected]

Website: www.caplinpoint.net

Registrar & Transfer Agent: Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

Address: II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai, II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar | Phone: 044-28140801 | Fax: 044-28142479

Email: [email protected]

Essential checks
Altman Z-Score
16.83
Piotroski F-Score
5
Modified C-Score
3
5-Years Price to Earnings
11.54
5-Years Price to Book
3.02
Earnings Yield
EBIT / Enterprise value
12.04%
PEG
Price / Earnings to growth ratio
0.25
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,782.10 +4.90%
Eris Lifesciences R493.00 +3.50%
FDC R206.50 +0.12%
Granules India R123.05 +1.28%
JB Chemicals & Pharma R400.50 -0.68%
Laurus Labs R336.50 -1.09%
Procter & Gamble Health R4,270.00 +0.34%
Strides Pharma Science R373.45 -1.22%
Sun Pharma Adv. Research R166.85 +8.49%
Suven Life Sciences R275.00 -1.63%
As on Dec 09, 12:34